Moberg Derma and Paladin Labs Inc. Extends Agreement for Kerasal™ Nail to Mexico

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Moberg Pharma AB (OMX: MOB) today announced that Paladin has been granted the exclusive rights to market and sell Kerasal Nail™ in Mexico. Kerasal Nail™ is an over-the-counter (OTC), topical product with a unique mechanism of action that generates visible improvements within 2-4 weeks of treatment. Further details or financial terms of the transaction were not disclosed.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC